TRP-2, Tyrosinase-related Protein 2 (180-188) – 1 mg

Overview

Introducing TRP-2, Tyrosinase-related Protein 2 (180-188), a peptide recognized for its role in melanoma research. This specific peptide spans residues 180-188 of TRP2 and is part of the melanocyte differentiation antigens, which are crucial in the context of immunotherapy targeting both human and murine melanoma. By incorporating this peptide into your research, you can contribute to the understanding and development of effective melanoma therapies.

Key Features

• Derived from residues 180-188 of TRP2
• Targets melanocyte differentiation antigens
• Potential use in immunotherapy for melanoma
• Compatible with mouse and human MHC class I molecules
• Enhances antitumor immunity through dendritic cell immunization

Specifications

FAQ

What is TRP-2 and why is it important?

TRP-2 is a peptide that plays a significant role in the differentiation of melanocytes and is a promising target for immunotherapies aimed at melanoma. Its study can aid in the development of treatments enhancing tumor immunity.

How can I use TRP-2 in my research?

TRP-2 can be utilized in various settings, including binding assays with MHC class I molecules and as a component in dendritic cell based immunization protocols, potentially enhancing antitumor responses.

Where can I find more peptide options?

You can explore our extensive range of peptides including alternatives such as Autocamtide-2 or CREBtide for various applications.

Experience the potential of TRP-2, Tyrosinase-related Protein 2 (180-188) for your research needs. Shop now at AnaSpec and explore the possibilities of enhancing your studies on melanoma.

Related Products

• PKG Substrate [RKRSRAE], Glasstide

Browse more in Peptides.